GeoVax to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021 and Provide Corporate Update

NEXT STORY
Enzyvant Announces Publication of Positive Clinical Data in Pediatric Patients with Congenital Athymia Treated with Investigational RVT-802 (allogeneic processed thymus tissue-agdc)
PREV STORY
Global Nucleic Acid Isolation and Purification Markets 2021-2031: Emergence of Advanced Stabilization Products / Regulated vs. Multimodal / Novel Targets / New Applications
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Rafael Pharmaceuticals Announces Positive Preplanned Interim Futility Analysis of Pivotal Phase 3 Trial (ARMADA 2000) of CPI-613® (Devimistat) for Relapsed or Refractory Acute Myeloid Leukemia (AML)

author_avatar
NASDAQ Market News

BeyondSpring Appoints Richard J. Daly as Chief Operating Officer to Lead the Transition to Commercialization

Daly Brings Significant Commercial and Business Development Experience with Global Pharmaceutical CompaniesNEW YORK, Aug. ...

author_avatar
NASDAQ Market News

Todos Medical Announces Publication Demonstrating Potential of FTIR Platform to Identify Bacterial and Viral Infections

author_avatar
NASDAQ Market News